Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Synthesis, biochemical, pharmacological characterization and in silico profile modelling of highly potent opioid orvinol and thevinol derivatives.

Szűcs E, Marton J, Szabó Z, Hosztafi S, Kékesi G, Tuboly G, Bánki L, Horváth G, Szabó PT, Tömböly C, Varga ZK, Benyhe S, Ötvös F.

Eur J Med Chem. 2020 Apr 1;191:112145. doi: 10.1016/j.ejmech.2020.112145. Epub 2020 Feb 15.

PMID:
32092588
2.

Discovery of Kynurenines Containing Oligopeptides as Potent Opioid Receptor Agonists.

Szűcs E, Stefanucci A, Dimmito MP, Zádor F, Pieretti S, Zengin G, Vécsei L, Benyhe S, Nalli M, Mollica A.

Biomolecules. 2020 Feb 12;10(2). pii: E284. doi: 10.3390/biom10020284.

3.

Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions.

Zádor F, Nagy-Grócz G, Kekesi G, Dvorácskó S, Szűcs E, Tömböly C, Horvath G, Benyhe S, Vécsei L.

Molecules. 2019 Oct 15;24(20). pii: E3709. doi: 10.3390/molecules24203709. Review.

4.

Affinity of fentanyl and its derivatives for the σ1-receptor.

Lipiński PFJ, Szűcs E, Jarończyk M, Kosson P, Benyhe S, Misicka A, Dobrowolski JC, Sadlej J.

Medchemcomm. 2019 Jun 13;10(7):1187-1191. doi: 10.1039/c9md00222g. eCollection 2019 Jul 1.

PMID:
31391893
5.

Biochemical and pharmacological investigation of novel nociceptin/OFQ analogues and N/OFQ-RYYRIK hybrid peptides.

Erdei AI, Borbély A, Magyar A, Szűcs E, Ötvös F, Gombos D, Al-Khrasani M, Stefanucci A, Dimmito MP, Luisi G, Mollica A, Benyhe S.

Peptides. 2019 Feb;112:106-113. doi: 10.1016/j.peptides.2018.11.010. Epub 2018 Dec 1.

PMID:
30513351
6.

Alterations in the Activity of Spinal and Thalamic Opioid Systems in a Mice Neuropathic Pain Model.

Rojewska E, Wawrzczak-Bargiela A, Szucs E, Benyhe S, Starnowska J, Mika J, Przewlocki R, Przewlocka B.

Neuroscience. 2018 Oct 15;390:293-302. doi: 10.1016/j.neuroscience.2018.08.013. Epub 2018 Sep 1.

PMID:
30176322
7.

Biochemical and pharmacological characterization of three opioid-nociceptin hybrid peptide ligands reveals substantially differing modes of their actions.

Erdei AI, Borbély A, Magyar A, Taricska N, Perczel A, Zsíros O, Garab G, Szűcs E, Ötvös F, Zádor F, Balogh M, Al-Khrasani M, Benyhe S.

Peptides. 2018 Jan;99:205-216. doi: 10.1016/j.peptides.2017.10.005. Epub 2017 Oct 13.

PMID:
29038035
8.

14-O-Methylmorphine: A Novel Selective Mu-Opioid Receptor Agonist with High Efficacy and Affinity.

Zádor F, Balogh M, Váradi A, Zádori ZS, Király K, Szűcs E, Varga B, Lázár B, Hosztafi S, Riba P, Benyhe S, Fürst S, Al-Khrasani M.

Eur J Pharmacol. 2017 Nov 5;814:264-273. doi: 10.1016/j.ejphar.2017.08.034. Epub 2017 Aug 30.

PMID:
28864212
9.

Cyclic Biphalin Analogues Incorporating a Xylene Bridge: Synthesis, Characterization, and Biological Profile.

Stefanucci A, Carotenuto A, Macedonio G, Novellino E, Pieretti S, Marzoli F, Szűcs E, Erdei AI, Zádor F, Benyhe S, Mollica A.

ACS Med Chem Lett. 2017 Jul 12;8(8):858-863. doi: 10.1021/acsmedchemlett.7b00210. eCollection 2017 Aug 10.

10.

Opioid Receptor Activity and Analgesic Potency of DPDPE Peptide Analogues Containing a Xylene Bridge.

Stefanucci A, Novellino E, Mirzaie S, Macedonio G, Pieretti S, Minosi P, Szűcs E, Erdei AI, Zádor F, Benyhe S, Mollica A.

ACS Med Chem Lett. 2017 Mar 14;8(4):449-454. doi: 10.1021/acsmedchemlett.7b00044. eCollection 2017 Apr 13.

11.

Kynurenic acid and its analogue can alter the opioid receptor G-protein signaling after acute treatment via NMDA receptor in rat cortex and striatum.

Samavati R, Zádor F, Szűcs E, Tuka B, Martos D, Veres G, Gáspár R, Mándity IM, Fülöp F, Vécsei L, Benyhe S, Borsodi A.

J Neurol Sci. 2017 May 15;376:63-70. doi: 10.1016/j.jns.2017.02.053. Epub 2017 Feb 27.

PMID:
28431630
12.

Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors.

Mollica A, Pelliccia S, Famiglini V, Stefanucci A, Macedonio G, Chiavaroli A, Orlando G, Brunetti L, Ferrante C, Pieretti S, Novellino E, Benyhe S, Zador F, Erdei A, Szucs E, Samavati R, Dvrorasko S, Tomboly C, Ragno R, Patsilinakos A, Silvestri R.

J Enzyme Inhib Med Chem. 2017 Dec;32(1):444-451. doi: 10.1080/14756366.2016.1260565.

13.

Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia.

Szűcs E, Dvorácskó S, Tömböly C, Büki A, Kékesi G, Horváth G, Benyhe S.

Neurosci Lett. 2016 Oct 28;633:87-93. doi: 10.1016/j.neulet.2016.09.020. Epub 2016 Sep 14.

PMID:
27639959
14.

Evaluation of the analgesic effect of 4-anilidopiperidine scaffold containing ureas and carbamates.

Monti L, Stefanucci A, Pieretti S, Marzoli F, Fidanza L, Mollica A, Mirzaie S, Carradori S, De Petrocellis L, Schiano Moriello A, Benyhe S, Zádor F, Szűcs E, Ötvös F, Erdei AI, Samavati R, Dvorácskó S, Tömböly C, Novellino E.

J Enzyme Inhib Med Chem. 2016 Dec;31(6):1638-47. doi: 10.3109/14756366.2016.1160902. Epub 2016 Apr 11.

PMID:
27063555
15.

Mu-Opioid (MOP) receptor mediated G-protein signaling is impaired in specific brain regions in a rat model of schizophrenia.

Szűcs E, Büki A, Kékesi G, Horváth G, Benyhe S.

Neurosci Lett. 2016 Apr 21;619:29-33. doi: 10.1016/j.neulet.2016.02.060. Epub 2016 Mar 2.

PMID:
26946106

Supplemental Content

Loading ...
Support Center